20413 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine Spiro-condensed pyrazines or piperazines
PIPERAZINE SUBSTITUTED PHENOL DERIVATIVE AND USE THEREOF
#2PAPD5 INHIBITORS AND METHODS OF USE THEREOF
#3NEW THERAPEUTIC APPROACH TO LUNG DISEASE
#4Injectable Composition For Drug Delivery
#5COMPOUNDS FOR TARGETED PROTEIN DEGRADATION
#6COMPOUNDS FOR TARGETED PROTEIN DEGRADATION
#7NOVEL COMPOUNDS AND USES THEREOF
#8POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION THEREOF
#9METHODS OF TREATING WHSC1-OVEREXPRESSING CANCERS BY INHIBITING SETD2
#10SIALIC ACID DERIVATIVES AND METHODS OF USING SAME
#11BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF
#12HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
#13HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
#14T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOF
#15WEE1 DEGRADING COMPOUNDS AND USES THEREOF
#16SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS
#17SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS
#18INHIBITORS OF TRPC6 FOR TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
#19NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE PARP INHIBITOR AND USE THEREOF
#20PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#216-SUBSTITUTED INDOLE COMPOUNDS
#22Compounds for the Degradation of EGFR Kinase
#23PARG INHIBITORY COMPOUNDS
#24TREATMENT AND DETECTION OF INHERITED NEUROPATHIES AND ASSOCIATED DISORDERS
#25MEDICINE FOR PREVENTION AND TREATMENT OF DISEASES LINKED TO ANTI-OBESITY ACTIVITY
#26NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
#27PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN
#285-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T
#29MACROCYCLIC EGFR INHIBITORS FOR THE TREATMENT OF CANCER
#30METHOD FOR TREATING NEUROLOGICAL DISEASES USING SUPRAMOLECULE POLYMER THERAPEUTICS
#31CDK INHIBITORS
#32TREATMENT OF MIGRAINE
#33TREATMENT AND DETECTION OF INHERITED NEUROPATHIES AND ASSOCIATED DISORDERS
#34ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIBITOR COMPOUNDS TO TREAT RB-POSITIVE TUMORS
#35Pyrazole MAGL inhibitors
#36SPIRO-LACTAM COMPOUNDS AND METHODS OF TREATING VIRAL INFECTIONS USING THE SAME
#37ADMINISTRATION OF CALCIUM CHANNEL TRPC6 INHIBITORS USING BALLOONS, STENTS OR OTHER MEDICAL DEVICES
#38SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
#39METHODS OF TREATING WHSC1-OVEREXPRESSING CANCERS BY INHIBITING SETD2
#40Compositions and methods for treating neurological disorders
#41INHIBITORS OF CBL-B AND METHODS OF USE THEREOF
#42Treatment and detection of inherited neuropathies and associated disorders
#43NEW THERAPEUTIC APPROACH TO LUNG DISEASE
#44INDUCING FAVORABLE EFFECTS ON TUMOR MICROENVIRONMENT VIA ADMINISTRATION OF NANOPARTICLE COMPOSITIONS
#45Compounds and pharmaceutical uses thereof
#46TREATMENT AND DETECTION OF INHERITED NEUROPATHIES AND ASSOCIATED DISORDERS
#47Aromatic heterocyclic compound, and pharmaceutical composition and use thereof
#48CDK INHIBITORS
#49Method for inhibiting virus infection and replication
#50NON PEPTIDIC HETEROBIVALENT MOLECULES FOR TREATING INFLAMMATORY DISEASES
#51NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS
#525-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR ENHANCING IN VIVO ENGRAFTMENT POTENTIAL
#53Spiro-lactam NMDA receptor modulators and uses thereof
#54DECREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
#55Compounds and pharmaceutical uses thereof
#56CCR5 BINDING AGENT FOR THE TREATMENT OF CCR5 POSITIVE METASTATIC CANCER
#57PAPD5 inhibitors and methods of use thereof
#58Compounds and compositions for the treatment of parasitic diseases
#59Compositions and methods for treating neurological disorders
#60Methods of treating anxiety by administering a substituted quinolone
#61CDK inhibitors
#62Nicotinic acetylcholine receptor silent agonists
#63Benzothiophene estrogen receptor modulators
#64Pharmaceutical compound
#65Bicyclic compounds and methods for their use in treating autism
#66Spirocycle compounds and methods of making and using same
#67Substituted Heterocyclic Compounds as Inhibitors of PRDM9
#68NON PEPTIDE HETEROBIVALENT MOLECULES FOR TREATING INFLAMMATORY DISEASES
#69Spiro-lactam NMDA receptor modulators and uses thereof
#70Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors
#71Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
#72SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#73SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#74SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#75CDK inhibitors
#76Benzothiophene estrogen receptor modulators
#77Composition comprising fine particle and process thereof
#78Mutant IDH1 inhibitors useful for treating cancer
#79Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
#80Pharmaceutical compound
#815-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential
#82Nicotinic acetylcholine receptor silent agonists
#83Benzothiophene estrogen receptor modulators
#84CDK inhibitors
#85CDK inhibitors
#86CDK inhibitors
#87Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
#88Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
#89CGRP RECEPTOR ANTAGONIST COMPOUNDS FOR TOPICAL TREATMENT OF SKIN DISORDERS
#90Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#91Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders
#92Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death
#93Spirocyclic heterocyclic compounds useful as HIV integrase inhibitors
#94Ophthalmic suspension formulation
#95ALGORITHMS FOR GENE SIGNATURE-BASED PREDICTOR OF SENSITIVITY TO MDM2 INHIBITORS
#96Inhibitors of the renal outer medullary potassium channel
#97Spirocyclic derivatives
#98Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors
#99Pyrrolopyrazine-Spirocyclic piperidine amides as modulators of ion channels
#100Pyridyl piperidines
#101Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors
#102CDK inhibitors
#103Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor
#104Heterocyclic compound
#105Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders
#106Spirocyclic hetercycle compounds useful as HIV integrase inhibitors
#107Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death
#108Phenol derivatives and pharmaceutical or cosmetic use thereof
#109HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE
#110SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
#1112-aminopyridine compounds
#112Substituted cyanoguanidines as oral anti-virals
#113CDK inhibitors
#114CDK inhibitors
#115Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
#116Medicinal Agent for Prevention or Treatment of Diseases Associated with Intraocular Neovascularization and/or Intraocular Vascular Hyperpermeability
#117Phenol derivatives and pharmaceutical or cosmetic use thereof
#118SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
#119Substituted indole derivatives
#120Compositions and methods of preventing or ameliorating abnormal thrombus formation and cardiovascular disease
#121Chemically Programmed Vaccination
#122Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
#123FATTY ACID SYNTHASE INHIBITORS
#124Imidazothiazole Derivatives Having Proline Ring Structure
#125Substituted indole derivatives
#126Methods involving aldose reductase inhibitors
#127Methods involving aldose reductase inhibitors
#128Combination Therapy Comprising A CCR5 Antagonist, A HIV-1 Protease Inhibtior and a Pharmacokinetic Enhancer
#129Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
#130Chemically programmed vaccination
#131Imidazothiazole derivatives having proline ring structure
#132Use of a PKC inhibitor
#133SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
#134Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy
#135AMPA Receptor Antagonists and Aldose Reductase Inhibitors for Neuropathic Pain
#136USE OF PKC INHIBITORS IN OCULAR DISEASES
#137Methods involving aldose reductase inhibitors
#138Function Inhibitor of Effector Cell
#139Anti-first-pass effect compounds
#140Nitrogen-containing heterocyclic compounds and use thereof
#141Fast-dissolving pharmaceutical composition
#142Five-membered heterocyclic derivative
#143Method for treating HIV infection through co-administration of tipranavir and GW873140
#144Remedies for vertebral canal stenosis
#145Anti-first-pass effect compounds
#146Compositions and methods for modulating the endothelial barrier